 | • レポートコード：QFJ1-5762 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、成長ホルモン用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ノルディトロピン、ジェノトロピン、サイゼン、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・成長ホルモン用医薬品の市場動向 ・企業の競争状況、市場シェア ・成長ホルモン用医薬品の種類別市場規模と予測2016-2027（ノルディトロピン、ジェノトロピン、サイゼン、その他） ・成長ホルモン用医薬品の用途別市場規模と予測2016-2027（小売薬局、病院薬局、オンライン薬局） ・成長ホルモン用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・成長ホルモン用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・成長ホルモン用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・成長ホルモン用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・成長ホルモン用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Roche、Novartis、Novo Nordisk、Eli Lilly、Pfizer、Aeterna Zentaris、Biogenomics、Critical Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Growth Hormone Drug Market
The global Growth Hormone Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Growth Hormone Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Growth Hormone Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Growth Hormone Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Growth Hormone Drug market.
Global Growth Hormone Drug Scope and Market Size
Growth Hormone Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Norditropin
Genotropin
Saizen
Other
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Roche
Novartis
Novo Nordisk
Eli Lilly
Pfizer
Aeterna Zentaris
Biogenomics
Critical Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Growth Hormone Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Saizen
1.2.5 Other
1.3 Market by Application
1.3.1 Global Growth Hormone Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Growth Hormone Drug Market Perspective (2016-2027)
2.2 Growth Hormone Drug Growth Trends by Regions
2.2.1 Growth Hormone Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Growth Hormone Drug Historic Market Share by Regions (2016-2021)
2.2.3 Growth Hormone Drug Forecasted Market Size by Regions (2022-2027)
2.3 Growth Hormone Drug Industry Dynamic
2.3.1 Growth Hormone Drug Market Trends
2.3.2 Growth Hormone Drug Market Drivers
2.3.3 Growth Hormone Drug Market Challenges
2.3.4 Growth Hormone Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Growth Hormone Drug Players by Revenue
3.1.1 Global Top Growth Hormone Drug Players by Revenue (2016-2021)
3.1.2 Global Growth Hormone Drug Revenue Market Share by Players (2016-2021)
3.2 Global Growth Hormone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Growth Hormone Drug Revenue
3.4 Global Growth Hormone Drug Market Concentration Ratio
3.4.1 Global Growth Hormone Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Growth Hormone Drug Revenue in 2020
3.5 Growth Hormone Drug Key Players Head office and Area Served
3.6 Key Players Growth Hormone Drug Product Solution and Service
3.7 Date of Enter into Growth Hormone Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Growth Hormone Drug Breakdown Data by Type
4.1 Global Growth Hormone Drug Historic Market Size by Type (2016-2021)
4.2 Global Growth Hormone Drug Forecasted Market Size by Type (2022-2027)
5 Growth Hormone Drug Breakdown Data by Application
5.1 Global Growth Hormone Drug Historic Market Size by Application (2016-2021)
5.2 Global Growth Hormone Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Growth Hormone Drug Market Size (2016-2027)
6.2 North America Growth Hormone Drug Market Size by Type
6.2.1 North America Growth Hormone Drug Market Size by Type (2016-2021)
6.2.2 North America Growth Hormone Drug Market Size by Type (2022-2027)
6.2.3 North America Growth Hormone Drug Market Size by Type (2016-2027)
6.3 North America Growth Hormone Drug Market Size by Application
6.3.1 North America Growth Hormone Drug Market Size by Application (2016-2021)
6.3.2 North America Growth Hormone Drug Market Size by Application (2022-2027)
6.3.3 North America Growth Hormone Drug Market Size by Application (2016-2027)
6.4 North America Growth Hormone Drug Market Size by Country
6.4.1 North America Growth Hormone Drug Market Size by Country (2016-2021)
6.4.2 North America Growth Hormone Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Growth Hormone Drug Market Size (2016-2027)
7.2 Europe Growth Hormone Drug Market Size by Type
7.2.1 Europe Growth Hormone Drug Market Size by Type (2016-2021)
7.2.2 Europe Growth Hormone Drug Market Size by Type (2022-2027)
7.2.3 Europe Growth Hormone Drug Market Size by Type (2016-2027)
7.3 Europe Growth Hormone Drug Market Size by Application
7.3.1 Europe Growth Hormone Drug Market Size by Application (2016-2021)
7.3.2 Europe Growth Hormone Drug Market Size by Application (2022-2027)
7.3.3 Europe Growth Hormone Drug Market Size by Application (2016-2027)
7.4 Europe Growth Hormone Drug Market Size by Country
7.4.1 Europe Growth Hormone Drug Market Size by Country (2016-2021)
7.4.2 Europe Growth Hormone Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Growth Hormone Drug Market Size (2016-2027)
8.2 Asia-Pacific Growth Hormone Drug Market Size by Type
8.2.1 Asia-Pacific Growth Hormone Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Growth Hormone Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Growth Hormone Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Growth Hormone Drug Market Size by Application
8.3.1 Asia-Pacific Growth Hormone Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Growth Hormone Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Growth Hormone Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Growth Hormone Drug Market Size by Region
8.4.1 Asia-Pacific Growth Hormone Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Growth Hormone Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Growth Hormone Drug Market Size (2016-2027)
9.2 Latin America Growth Hormone Drug Market Size by Type
9.2.1 Latin America Growth Hormone Drug Market Size by Type (2016-2021)
9.2.2 Latin America Growth Hormone Drug Market Size by Type (2022-2027)
9.2.3 Latin America Growth Hormone Drug Market Size by Type (2016-2027)
9.3 Latin America Growth Hormone Drug Market Size by Application
9.3.1 Latin America Growth Hormone Drug Market Size by Application (2016-2021)
9.3.2 Latin America Growth Hormone Drug Market Size by Application (2022-2027)
9.3.3 Latin America Growth Hormone Drug Market Size by Application (2016-2027)
9.4 Latin America Growth Hormone Drug Market Size by Country
9.4.1 Latin America Growth Hormone Drug Market Size by Country (2016-2021)
9.4.2 Latin America Growth Hormone Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Growth Hormone Drug Market Size (2016-2027)
10.2 Middle East & Africa Growth Hormone Drug Market Size by Type
10.2.1 Middle East & Africa Growth Hormone Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Growth Hormone Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Growth Hormone Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Growth Hormone Drug Market Size by Application
10.3.1 Middle East & Africa Growth Hormone Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Growth Hormone Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Growth Hormone Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Growth Hormone Drug Market Size by Country
10.4.1 Middle East & Africa Growth Hormone Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Growth Hormone Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Growth Hormone Drug Introduction
11.1.4 Merck Revenue in Growth Hormone Drug Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Growth Hormone Drug Introduction
11.2.4 Roche Revenue in Growth Hormone Drug Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Growth Hormone Drug Introduction
11.3.4 Novartis Revenue in Growth Hormone Drug Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Growth Hormone Drug Introduction
11.4.4 Novo Nordisk Revenue in Growth Hormone Drug Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Growth Hormone Drug Introduction
11.5.4 Eli Lilly Revenue in Growth Hormone Drug Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Growth Hormone Drug Introduction
11.6.4 Pfizer Revenue in Growth Hormone Drug Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Aeterna Zentaris
11.7.1 Aeterna Zentaris Company Details
11.7.2 Aeterna Zentaris Business Overview
11.7.3 Aeterna Zentaris Growth Hormone Drug Introduction
11.7.4 Aeterna Zentaris Revenue in Growth Hormone Drug Business (2016-2021)
11.7.5 Aeterna Zentaris Recent Development
11.8 Biogenomics
11.8.1 Biogenomics Company Details
11.8.2 Biogenomics Business Overview
11.8.3 Biogenomics Growth Hormone Drug Introduction
11.8.4 Biogenomics Revenue in Growth Hormone Drug Business (2016-2021)
11.8.5 Biogenomics Recent Development
11.9 Critical Pharmaceuticals
11.9.1 Critical Pharmaceuticals Company Details
11.9.2 Critical Pharmaceuticals Business Overview
11.9.3 Critical Pharmaceuticals Growth Hormone Drug Introduction
11.9.4 Critical Pharmaceuticals Revenue in Growth Hormone Drug Business (2016-2021)
11.9.5 Critical Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Growth Hormone Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Norditropin
Table 3. Key Players of Genotropin
Table 4. Key Players of Saizen
Table 5. Key Players of Other
Table 6. Global Growth Hormone Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Growth Hormone Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Growth Hormone Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Growth Hormone Drug Market Share by Regions (2016-2021)
Table 10. Global Growth Hormone Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Growth Hormone Drug Market Share by Regions (2022-2027)
Table 12. Growth Hormone Drug Market Trends
Table 13. Growth Hormone Drug Market Drivers
Table 14. Growth Hormone Drug Market Challenges
Table 15. Growth Hormone Drug Market Restraints
Table 16. Global Growth Hormone Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Growth Hormone Drug Market Share by Players (2016-2021)
Table 18. Global Top Growth Hormone Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Drug as of 2020)
Table 19. Ranking of Global Top Growth Hormone Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Growth Hormone Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Growth Hormone Drug Product Solution and Service
Table 23. Date of Enter into Growth Hormone Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Growth Hormone Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Growth Hormone Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Growth Hormone Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Growth Hormone Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Growth Hormone Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Growth Hormone Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Growth Hormone Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Growth Hormone Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Growth Hormone Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Growth Hormone Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Growth Hormone Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Growth Hormone Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Growth Hormone Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Growth Hormone Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Growth Hormone Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Growth Hormone Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Growth Hormone Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Growth Hormone Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Growth Hormone Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Growth Hormone Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Growth Hormone Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Growth Hormone Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Growth Hormone Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Growth Hormone Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Growth Hormone Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Growth Hormone Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Growth Hormone Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Growth Hormone Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Growth Hormone Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Growth Hormone Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Growth Hormone Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Growth Hormone Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Growth Hormone Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Growth Hormone Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Growth Hormone Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Growth Hormone Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Growth Hormone Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Growth Hormone Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Growth Hormone Drug Product
Table 66. Merck Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Growth Hormone Drug Product
Table 71. Roche Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Growth Hormone Drug Product
Table 76. Novartis Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Novo Nordisk Company Details
Table 79. Novo Nordisk Business Overview
Table 80. Novo Nordisk Growth Hormone Drug Product
Table 81. Novo Nordisk Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 82. Novo Nordisk Recent Development
Table 83. Eli Lilly Company Details
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Growth Hormone Drug Product
Table 86. Eli Lilly Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Growth Hormone Drug Product
Table 91. Pfizer Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Aeterna Zentaris Company Details
Table 94. Aeterna Zentaris Business Overview
Table 95. Aeterna Zentaris Growth Hormone Drug Product
Table 96. Aeterna Zentaris Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 97. Aeterna Zentaris Recent Development
Table 98. Biogenomics Company Details
Table 99. Biogenomics Business Overview
Table 100. Biogenomics Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 101. Biogenomics Recent Development
Table 102. Critical Pharmaceuticals Company Details
Table 103. Critical Pharmaceuticals Business Overview
Table 104. Critical Pharmaceuticals Growth Hormone Drug Product
Table 105. Critical Pharmaceuticals Revenue in Growth Hormone Drug Business (2016-2021) & (US$ Million)
Table 106. Critical Pharmaceuticals Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Growth Hormone Drug Market Share by Type: 2020 VS 2027
Figure 2. Norditropin Features
Figure 3. Genotropin Features
Figure 4. Saizen Features
Figure 5. Other Features
Figure 6. Global Growth Hormone Drug Market Share by Application: 2020 VS 2027
Figure 7. Retail Pharmacies Case Studies
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Growth Hormone Drug Report Years Considered
Figure 11. Global Growth Hormone Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Growth Hormone Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Growth Hormone Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Growth Hormone Drug Market Share by Regions (2022-2027)
Figure 15. Global Growth Hormone Drug Market Share by Players in 2020
Figure 16. Global Top Growth Hormone Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth Hormone Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Growth Hormone Drug Revenue in 2020
Figure 18. Global Growth Hormone Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Growth Hormone Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Growth Hormone Drug Market Share by Type (2016-2027)
Figure 22. North America Growth Hormone Drug Market Share by Application (2016-2027)
Figure 23. North America Growth Hormone Drug Market Share by Country (2016-2027)
Figure 24. United States Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Growth Hormone Drug Market Share by Type (2016-2027)
Figure 28. Europe Growth Hormone Drug Market Share by Application (2016-2027)
Figure 29. Europe Growth Hormone Drug Market Share by Country (2016-2027)
Figure 30. Germany Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Growth Hormone Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Growth Hormone Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Growth Hormone Drug Market Share by Region (2016-2027)
Figure 40. China Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Growth Hormone Drug Market Share by Type (2016-2027)
Figure 48. Latin America Growth Hormone Drug Market Share by Application (2016-2027)
Figure 49. Latin America Growth Hormone Drug Market Share by Country (2016-2027)
Figure 50. Mexico Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Growth Hormone Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Growth Hormone Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Growth Hormone Drug Market Share by Country (2016-2027)
Figure 56. Turkey Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Growth Hormone Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 65. Aeterna Zentaris Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 66. Biogenomics Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 67. Critical Pharmaceuticals Revenue Growth Rate in Growth Hormone Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
成長ホルモン剤のグローバル市場調査 2019年 The global Growth Hormone Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Growth Hormone Drug volume and value at global level, regional level and company level. From a global perspective, this…- 甲状腺ホルモン障害薬のグローバル市場調査 2019年 The global Thyroid Hormone Disorder Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Thyroid Hormone Disorder Drug volume and value at global level, regional level and company level. From a glob…
- 甲状腺ホルモン障害薬のグローバル市場調査 2019年 The global Thyroid Hormone Disorder Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Thyroid Hormone Disorder Drug volume and value at global level, regional level and company level. From a glob…
- 世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…
- 世界の向精神薬市場規模・現状・予測（2021年-2027年） The majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient. Market Analysis and Insights: Global Psychotropic Drug Market The global Psychotropic Drug market size is projec…